Default company panoramic image
825f3f30 cde9 46ae b0c2 2eef33ab684d

A V Therapeutics, inc.

Major shift in treating Prostate Cancer, 100% focused on disease vs. the 10% or less of hormone based treatments + new Therapeutic Vac.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location New York City, NY, USA
  • Currency USD
  • Founded April 2007
  • Employees 8
  • Website avtherapeutics.com

Company Summary

A mature/newest science technology representing a major paradigm shift in the treatment of Prostate Cancer with a low toxicity Capridine chemo drug (capable of being mixed with 200 other approved agents to lower the overall treatment toxicity) & a new Therapeutic Vaccine, four patents, world class Clinicians & Science team . For all the right reasons, we have purposely maintained a stealthy presence until now. Our new Medical Advisory Bd.

Team

  • Default avatar
    Abe Mittleman, MD
    CEO

    See slides

  • Default avatar
    Morton Coleman, MD
    Sr.VP &Director

    See slidee & please google him
    Head of the Lymphoma, etc diseases at NYP Weill Cornell Hospital & Medical School

  • Default avatar
    Howard Scher, MD
    Director

    @ SKMCC and head of the 13 university Prosatate Consortium

  • Default avatar
    Raj Tiawari
    CSO

    See slide & originator of our 4 patents

Advisors

  • Default avatar
    Merrill Kraines, Fulbright.com
    Lawyer
    Unconfirmed
    Default avatar
    Morton Gelb, Morton A Gelb, CPA,LLC
    Accountant
    Unconfirmed